Partner, The Retina Institute Professor of Clinical Ophthalmology Washington University
Ophthalmology
Dr. Kevin J. Blinder, MD
|
|
Give Review
Kevin Blinder practices Ophthalmology. He attended University of Missouri - Kansas City School of Medicine. He received 1 awards: "Fellow (FAAO)". Dr. Kevin J. Blinder is a published MD. He published 28 publications, including: 'Laser therapy versus observation for symptomatic retinal artery macroaneurysms.' He is registered with Medicare.
Publications
- Laser therapy versus observation for symptomatic retinal artery macroaneurysms.
- Sustained Visual Acuity Loss in the Comparison of Age-Related Macular Degeneration Treatments Trials.
- Internal limiting membrane peeling for primary rhegmatogenous retinal detachment repair.
- Techniques, Rationale, and Outcomes of Internal Limiting Membrane Peeling.
- Intravitreal bevacizumab for the treatment of refractory diabetic Macular edema.
- Surgical outcome of scleral buckling compared with scleral buckling with vitrectomy for treatment of macula-off retinal detachment.
- Incidence of Endophthalmitis related to intravitreal injection of bevacizumab and ranibizumab.
- Intravitreal bevacizumab for Choroidal neovascularization in ocular histoplasmosis.
- Intravitreal injection of bevacizumab combined with verteporfin photodynamic therapy for choroidal neovascularization in age-related Macular degeneration.
- Reversible cystoid Macular edema secondary to fingolimod in a renal transplant recipient.
- Surface anesthesia for office-based retinal procedures.
- The Macular automated photostress test.
- Combined photodynamic therapy with verteporfin and intravitreal bevacizumab for choroidal neovascularization in age-related Macular degeneration.
- Retinal pigment epithelial tear following intravitreal pegaptanib sodium.
- Vitreous and aqueous penetration of orally administered moxifloxacin in humans.
- Short-term intraOcular pressure trends following intravitreal pegaptanib (Macugen) injection.
- Triamcinolone-assisted internal limiting membrane peeling.
- Surgical removal of peripapillary choroidal neovascularization associated with age-related Macular degeneration.
- Penetration pharmacokinetics of topically administered 0.5% moxifloxacin ophthalmic solution in human aqueous and vitreous.
- Photodynamic therapy for juxtafoveal Choroidal neovascularization due to ocular histoplasmosis syndrome.
- Femtosecond laser-induced preMacular hemorrhage.
- Intruding scleral sutures 12 years after primary repair.
- Outcome of Macular hole surgery in diabetic patients with nonproliferative retinopathy.
- Human intraOcular penetration pharmacokinetics of moxifloxacin 0.5% via topical and collagen shield routes of administration.
- Outcome results in Macular hole surgery: an evaluation of internal limiting membrane peeling with and without indocyanine green.
- Verteporfin therapy of subfoveal Choroidal neovascularization in pathologic myopia: 2-year results of a randomized clinical trial--VIP report no. 3.
- Bilateral Macular hole formation in a patient with retinitis pigmentosa.
Schools
University of Missouri Kansas City Campus
St Marys Health Center
University Mo
Lsu Eye Center
Procedures Preformed
- Cataract Removal Surgery
- Destruction of Lesion of Retina and Choroid
- Enucleation of Eye
- Repair of Retinal Detachment or Retinal Tear
- View All
Conditions Treated
- Acute Endophthalmitis
- Age-Related Macular Degeneration
- Anterior Ischemic Optic Neuropathy
- Aphakia and Other Disorders of Lens
- View All
Doctors Specialties
- Ophthalmology
Accepted Insurances
Awards
- Fellow (FAAO)
Education
-
Louisiana State University -
University of Missouri-Columbia -
University of Missouri - Kansas City School of Medicine
Hospital
-
St. Luke's Hospital
Drug Facts
| NPI NUMBER | 1669476560 | |
| NPPES Provider LastName | BLINDER | |
| NPPES Provider FirstName | KEVIN | |
| NPPES Provider ZIPCode | 631171118 | |
| NPPES Provider State | MO | |
| Specialty Description | Ophthalmology | |
| Total Claim Count | 646.0 | |
| Distinct Opioid Count | 1.0 | |
| Opioid Claim Count | 15.0 | |
| Percent Opioid Claims | 2.32 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1669476560 |
| Last Name Of The Provider | BLINDER |
| First Name Of The Provider | KEVIN |
| View All |
Similar Doctors
|
|
Dr. Sidney J. Hanish, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Morris E. Hartstein, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Gerald A. Wankum, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. M G. Grand, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Nicholas Engelbrecht, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Matthew A. Thomas, MD |
|
|
Dr. Nathan P. Hesemann, MD
This Doctor is OpenDoctor Recommended.
|